WallStSmart

Ambow Education Holding Ltd (AMBO)vsCovista Inc. (CVSA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Covista Inc. generates 19848% more annual revenue ($1.89B vs $9.47M). AMBO leads profitability with a 14.3% profit margin vs 13.4%. AMBO appears more attractively valued with a PEG of 0.12. CVSA earns a higher WallStSmart Score of 67/100 (B-).

AMBO

Buy

62

out of 100

Grade: C+

Growth: 3.3Profit: 5.0Value: 10.0Quality: 6.0
Piotroski: 3/9Altman Z: -238.28

CVSA

Strong Buy

67

out of 100

Grade: B-

Growth: 5.3Profit: 7.5Value: 8.3Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AMBOUndervalued (+88.3%)

Margin of Safety

+88.3%

Fair Value

$22.00

Current Price

$1.93

$20.07 discount

UndervaluedFair: $22.00Overvalued
CVSASignificantly Overvalued (N/A)

Margin of Safety

N/A

Fair Value

$97.23

Current Price

$113.08

$15.85 premium

UndervaluedFair: $97.23Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMBO3 strengths · Avg: 10.0/10
PEG RatioValuation
0.1210/10

Growing faster than its price suggests

P/E RatioValuation
4.3x10/10

Attractively priced relative to earnings

Price/BookValuation
0.7x10/10

Reasonable price relative to book value

CVSA4 strengths · Avg: 8.0/10
PEG RatioValuation
0.818/10

Growing faster than its price suggests

P/E RatioValuation
16.1x8/10

Attractively priced relative to earnings

Price/BookValuation
2.8x8/10

Reasonable price relative to book value

Operating MarginProfitability
22.9%8/10

Strong operational efficiency at 22.9%

Areas to Watch

AMBO4 concerns · Avg: 2.5/10
Market CapQuality
$5.81M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Revenue GrowthGrowth
-5.0%2/10

Revenue declined 5.0%

Altman Z-ScoreHealth
-238.282/10

Distress zone — elevated risk

CVSA1 concerns · Avg: 4.0/10
EPS GrowthGrowth
4.7%4/10

4.7% earnings growth

Comparative Analysis Report

WallStSmart Research

Bull Case : AMBO

The strongest argument for AMBO centers on PEG Ratio, P/E Ratio, Price/Book. PEG of 0.12 suggests the stock is reasonably priced for its growth.

Bull Case : CVSA

The strongest argument for CVSA centers on PEG Ratio, P/E Ratio, Price/Book. Revenue growth of 12.4% demonstrates continued momentum. PEG of 0.81 suggests the stock is reasonably priced for its growth.

Bear Case : AMBO

The primary concerns for AMBO are Market Cap, Piotroski F-Score, Revenue Growth.

Bear Case : CVSA

The primary concerns for CVSA are EPS Growth.

Key Dynamics to Monitor

AMBO profiles as a declining stock while CVSA is a value play — different risk/reward profiles.

AMBO carries more volatility with a beta of 1.04 — expect wider price swings.

CVSA is growing revenue faster at 12.4% — sustainability is the question.

CVSA generates stronger free cash flow (15M), providing more financial flexibility.

Bottom Line

CVSA scores higher overall (67/100 vs 62/100) and 12.4% revenue growth. AMBO offers better value entry with a 88.3% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Ambow Education Holding Ltd

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · China

Ambow Education Holding Ltd. provides a range of educational and career enhancement products and services to students, recent graduates, corporate employees, and management professionals in the People's Republic of China. The company is headquartered in Beijing, the People's Republic of China.

Covista Inc.

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Covista Inc., provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. The company is headquartered in Chicago, Illinois.

Want to dig deeper into these stocks?